Venture Life Group (LON:VLG) Stock Price Down 0.7% – What’s Next?

Venture Life Group plc (LON:VLG)’s stock price was down 0.7% during trading on Thursday . The stock traded as low as GBX 36.60 ($0.46) and last traded at GBX 37.25 ($0.47). Approximately 58,251 shares were traded during mid-day trading, a decline of 68% from the average daily volume of 180,257 shares. The stock had previously closed at GBX 37.50 ($0.47).

Venture Life Group Stock Performance

The company’s 50-day simple moving average is GBX 40.86 and its 200 day simple moving average is GBX 43.88. The stock has a market cap of £47.33 million, a P/E ratio of 3,700.00, a PEG ratio of 5.67 and a beta of 0.30. The company has a current ratio of 2.22, a quick ratio of 1.48 and a debt-to-equity ratio of 28.45.

Insider Activity

In other news, insider Mark Adams purchased 116,496 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were purchased at an average price of GBX 43 ($0.54) per share, with a total value of £50,093.28 ($63,225.14). Insiders own 10.41% of the company’s stock.

Venture Life Group Company Profile

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids.